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CONSIDERATIONS ON T H E COMBINED V I R A L H E P A T I T I S 
AND TUBERCULOSIS A F F E C T I O N 
V. Zozikov, M. Radkov, V. Zheliazkova, D. Tzoncheva 
V i r a l hepatitis is considered as a widely spread infectious disease, not 
infrequently affecting tuberculosis patients. Therefore, having in mind 
that hepatic lesions in the course of tuberculosis might be also caused by 
the specific infection itself, or by the administered drugs wi th an eventual 
toxo-allergic effect, a number of essential epidemiological, diagnos-
t ica l and therapeutical problems arise, namely: is it a matter of a combi­
nation between v i r a l hepatitis ( V H ) and tuberculosis, or of' a hepatic le­
sion wi th other (specific or paraspeciSic) genesis, what therapeutical policy 
should be adopted (antituberculous means — hepatotoxit? glucocorticoids?), 
is there a possibility that clinico-laboratory changes occur in the course of 
either disease, are antiepidemic measures necessary, etc. 
As a rule, tuberculous patients are often affected wi th V H — in the opi­
nion of some authors — s ix times more frequently than the general popu­
lation (4). Th i s is attributed to their lowered bioresistance and to the fre­
quent pareneteral (inoculation) infection ( 1 , 6, 19). 
A number of antituberculous drugs ( P A S A , streptomycin, isonicotinic 
acid derivatives, pyrazinamide)" are capable to produce drug induced hepa­
t i t i s of a toxic and/or allergic nature. The data concerning the 
incidence and severity of the latter are quite discordant (3, 4, 5, 13, 14, 
17, 18, 20, 21). While Ka l inowsk i (18), out of a total of 3148 tuberculous 
patients undergoing treatment wi th P A S A , established a hepatic lesion 
in 0 Л 8 per cent only, Ugryumov and co-authors accept a toxo-allergic he­
patit is in 12 per cent out of a series of 600 patients, subjected to treatment 
wi th a variety of antituberculous agents. Moreover, there are reports des­
cribing hepatic dystrophy, caused by paraaminosalicylic acid ( P A S A ) (20). 
The opinions about the interference between V H and tuberculosis run­
ning a concomitant course are by no means convergent. Many authors fail 
to observe a mutual urtfavourble influence (2, 6, 8, 12, 16, 22). Luksha (9) 
supports the statement that V H in tuberculosis patients runs a milder c l i ­
nical course. Nevertheless, the reports on a unilateral or bilateral mutual 
negative influence are quite numerous (4, 7, 10, 15, 21). 
Usua l ly , V H in tuberculosis patients runs a heavier course. The latter fact 
is related as much to the unfavourable premorbid background (general 
chronic diseases, subclinical specific or iatrogenic hepatal lesion), as to the 
form of hepatitis itself (very often serum hepatitis which is usually 
heavier). 
I n the work submitted a series of 32 tuberculosis patients wi th concur­
rent V H affection are reviewed. They are of both sexes and various ages 
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(from 4—72, averaging 41.2 years). The tbc process disclosed the following 
localizations: lungs — 26 cases, bones and joints — 5, and peritoneum — 
one. Pulmonary tuberculosis wras in the phase of suction — 13 patients, 
decomposition — 6, and fibrosis — seven. The Mfection dated back 1 — 15 
years ago, or 5.2 years average. In four cases there was a past history of 
recent hemoptysis, and five were Koch-positive. F i v e patients were affected 
with a second chronic disease: cor pulmonale, ulcer and heart failure. 
Ten of the patients, by the time of V H affection, have undergone treat­
ment wi th streptomycin, P A S A and rimiphom The same scheme of the­
rapy was proceeded wi th after their admission to the irlfecti'ous c l i n i c . 
V H was diagnosed on the ground of a number of cr i ter ia , such as acute 
and cycl ic course, comparatively severe (in 12 patients serum bil irubin 
amounted to 1Ю—20 percent) and prolonged icterus (mean duration 14.7 
days), and considerable laboratory variations (substantial intensification 
of the ac t iv i ty of transaminases mainly) . The diagnosis was confirmed 
epidemiologically in eleven patients: in 3 of them serum hepatitis was 
considered highly probable (hemotransfusions sustained iti the last few 
months), whereas in 7 the same hepatitis form was merely suspected (fre­
quent dia£)nostic-laboratory and therapeutic-medicamentous injections). 
During the H V affection no detectable subjective or objective changes were 
noted in the course of tuberculosis. I n general, febrility, sweating and cough-
ing w ere 1 he same as before the occurrence of icterus. The X- ray controls 
l ikewise Tailed to reveal a ceterioraticn of the basic ccndition. 
T o clarify the question of the eventual influence exerted by the tuber-
culous background on the clinico-laboratory picture of V H , a comparison 
was made wi th a control group of 120 V H patients, free of preceding or 
coricomitant diseases. From the comparative table appended, it becomes 
evident that no one-way differences exist between the two groups of patients 
which would al low to accept wi th certainty a heavier or slighter course of 
the v i ra l hepatitis in tuberculous patients. 
A number of rather important indicators (such as a higher incidence of 
middle and heavy c l in ica l forms, longer hospitalization and bi l i rubinuria , 
more frequent hyperbilirubinemia, prolonged Weltmann test at discharge) 
point to a sl ightly heavier and rather protracted course of hepatitis among 
tuberculous patients. However, the impression upon comparative study 
of the remaining criteria is to the contrary (duration of icterus, hepatome-
gal ia , hypertransaminasemia, positive Mac lagan test upon discharge). 
Obviously, a l l differences referred to are by rlo means substantia!!, and most 
of them are stat is t ical ly unreliable. Nevertheless, the predomination of 
slight c l inical forms wi th ensuing considerably shorter hospitalization 
among the control cases is s ta t is t ical ly reliable, and most probably points 
to a sl ightly heavier course of hepatitis in tuberculous patients. 
The tuberculous patients were subjected to conventional treatment in 
compliance w i t h the c l in ica l form and severity of V H — mainly bed rest 
and dietary regimen, v i tamins and glucose (per os or intravenously). In 
four patients glucocorticoids were also prescribed, and no side effects what-
soever were recorded. 
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Clinical and Laboratory Characteristics of the Patients Reviewed 
Indicators 
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Insofar V H affection is concerned, the patients were dismissed wi th 
completely or almost completely subsided clfnical manifestations and wi th 
normal or close to normal laboratory results. No lethal cases were recorded. 
Conclusions 
1. There are quite reliable c l in ical and laboratory criteria for v i ra l hepa­
t i t is diagnosis in tuberculosis patients. 
2. The basic affection — tuberculosis — is not influenced perceptibly 
by the concurrent hepatitis. 
3. V i r u s hepatitis among tuberculosis patients does not show substan­
t ia l one-way clinico-laboratbry variations, but nevertheless, it runs up to a 
certain degree a sl ightly heavier and protracted course. 
4. The conventional hepatitis therapy leads to a good or satisfactory 
therapeutical outcome. 
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О С О Ч Е Т А Н И И ВИРУСНОГО ГЕПАТИТА 
С Т У Б Е Р К У Л Е З О М 
В. Зозиков, М. Радков, В. Желязкова, Д. Цончева 
Р Е З Ю М Е 
П р о с л е ж е н ы 32 больных туберкулезом, заболевших вирусным гепа­
титом. Проведено сравнение с другими 120 больными вирусным гепа­
титом, без сопровождающих других заболеваний. Вирусный гепатит у 
больных туберкулезом не показал значительных клинико-лабораторных 
отклонений в одном направлении, но до известной степени протекает 
немного т я ж е л е е и длительнее. Основное заболевание — туберкулез , гс-
влияетбя доловимо присоединившимся гепатитом. 
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